Stereospecific glucose transport across motor nerve terminal membrane: an electrophysiological study. 1983

Y Shimoni, and R Rahamimoff

Spontaneous transmitter release at the neuromuscular junction of the frog and rat was monitored during exposures to hyperosmotic solutions containing different sugars. Raising the osmolarity of the medium with D-glucose causes a marked, but transient, increase in the frequency of miniature end-plate potentials (MEPPs): after the initial elevation in frequency there is a subsequent decline towards the control levels, in spite of a continuous perfusion with the hyperosmotic solution. This decline occurs more rapidly in the frog. Two nonmetabolized analogues of glucose, 2-deoxy-D-glucose and 3-O-methylglucose, cause a transient hyperosmotic increase in MEPP frequency, which is very similar to the effect of D-glucose. The elevation of MEPP frequency with hyperosmotic glucose is stereospecific. Hyperosmotic solutions of L-glucose cause a sustained increase in transmitter release in the rat and frog. Insulin dramatically reduces the response of the frog nerve terminal to hyperosmotic D-glucose. Phenolphthalein, a glucose transport blocker, reduces or eliminates the secondary decline in MEPP frequency. It is suggested that the transient nature of the response to hyperosmotic solutions reflects the penetration of the hyperosmotic agent into the nerve terminal. The rate of decline of the MEPP frequency presumably indicates the rate of transport, which determines the rate of osmotic equilibration. This rate can then serve as an index of the relative permeability of the functioning presynaptic membrane to different sugars.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009004 Monosaccharide Transport Proteins A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES. Hexose Transport Proteins,Band 4.5 Preactin,Erythrocyte Band 4.5 Protein,Glucose Transport-Inducing Protein,Hexose Transporter,4.5 Preactin, Band,Glucose Transport Inducing Protein,Preactin, Band 4.5,Proteins, Monosaccharide Transport,Transport Proteins, Hexose,Transport Proteins, Monosaccharide,Transport-Inducing Protein, Glucose
D009045 Motor Endplate The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors. Motor End-Plate,End-Plate, Motor,End-Plates, Motor,Endplate, Motor,Endplates, Motor,Motor End Plate,Motor End-Plates,Motor Endplates
D009046 Motor Neurons Neurons which activate MUSCLE CELLS. Neurons, Motor,Alpha Motorneurons,Motoneurons,Motor Neurons, Alpha,Neurons, Alpha Motor,Alpha Motor Neuron,Alpha Motor Neurons,Alpha Motorneuron,Motoneuron,Motor Neuron,Motor Neuron, Alpha,Motorneuron, Alpha,Motorneurons, Alpha,Neuron, Alpha Motor,Neuron, Motor
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011895 Rana ridibunda A species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research.
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D005071 Evoked Potentials Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported. Event Related Potential,Event-Related Potentials,Evoked Potential,N100 Evoked Potential,P50 Evoked Potential,N1 Wave,N100 Evoked Potentials,N2 Wave,N200 Evoked Potentials,N3 Wave,N300 Evoked Potentials,N4 Wave,N400 Evoked Potentials,P2 Wave,P200 Evoked Potentials,P50 Evoked Potentials,P50 Wave,P600 Evoked Potentials,Potentials, Event-Related,Event Related Potentials,Event-Related Potential,Evoked Potential, N100,Evoked Potential, N200,Evoked Potential, N300,Evoked Potential, N400,Evoked Potential, P200,Evoked Potential, P50,Evoked Potential, P600,Evoked Potentials, N100,Evoked Potentials, N200,Evoked Potentials, N300,Evoked Potentials, N400,Evoked Potentials, P200,Evoked Potentials, P50,Evoked Potentials, P600,N1 Waves,N2 Waves,N200 Evoked Potential,N3 Waves,N300 Evoked Potential,N4 Waves,N400 Evoked Potential,P2 Waves,P200 Evoked Potential,P50 Waves,P600 Evoked Potential,Potential, Event Related,Potential, Event-Related,Potential, Evoked,Potentials, Event Related,Potentials, Evoked,Potentials, N400 Evoked,Related Potential, Event,Related Potentials, Event,Wave, N1,Wave, N2,Wave, N3,Wave, N4,Wave, P2,Wave, P50,Waves, N1,Waves, N2,Waves, N3,Waves, N4,Waves, P2,Waves, P50
D005690 Galactose An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood. D-Galactose,Galactopyranose,Galactopyranoside,D Galactose

Related Publications

Y Shimoni, and R Rahamimoff
January 1986, The Italian journal of biochemistry,
Y Shimoni, and R Rahamimoff
January 1988, Electromyography and clinical neurophysiology,
Y Shimoni, and R Rahamimoff
November 1981, Biochemical and biophysical research communications,
Y Shimoni, and R Rahamimoff
April 1963, The Journal of physiology,
Y Shimoni, and R Rahamimoff
September 1962, Journal of bacteriology,
Y Shimoni, and R Rahamimoff
June 1973, Archives of neurology,
Y Shimoni, and R Rahamimoff
January 1981, Lancet (London, England),
Y Shimoni, and R Rahamimoff
August 1972, Neurology,
Y Shimoni, and R Rahamimoff
April 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Copied contents to your clipboard!